Literature DB >> 18818197

Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv.

Kirsty J McLean1, Paul Carroll, D Geraint Lewis, Adrian J Dunford, Harriet E Seward, Rajasekhar Neeli, Myles R Cheesman, Laurent Marsollier, Philip Douglas, W Ewen Smith, Ida Rosenkrands, Stewart T Cole, David Leys, Tanya Parish, Andrew W Munro.   

Abstract

Mycobacterium tuberculosis (Mtb) cytochrome P450 gene CYP121 is shown to be essential for viability of the bacterium in vitro by gene knock-out with complementation. Production of CYP121 protein in Mtb cells is demonstrated. Minimum inhibitory concentration values for azole drugs against Mtb H37Rv were determined, the rank order of which correlated well with Kd values for their binding to CYP121. Solution-state spectroscopic, kinetic, and thermodynamic studies and crystal structure determination for a series of CYP121 active site mutants provide further insights into structure and biophysical features of the enzyme. Pro346 was shown to control heme cofactor conformation, whereas Arg386 is a critical determinant of heme potential, with an unprecedented 280-mV increase in heme iron redox potential in a R386L mutant. A homologous Mtb redox partner system was reconstituted and transported electrons faster to CYP121 R386L than to wild type CYP121. Heme potential was not perturbed in a F338H mutant, suggesting that a proposed P450 superfamily-wide role for the phylogenetically conserved phenylalanine in heme thermodynamic regulation is unlikely. Collectively, data point to an important cellular role for CYP121 and highlight its potential as a novel Mtb drug target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818197      PMCID: PMC2662266          DOI: 10.1074/jbc.M802115200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement.

Authors:  T Parish; N G Stoker
Journal:  Microbiology       Date:  2000-08       Impact factor: 2.777

2.  Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization.

Authors:  J S Miles; A W Munro; B N Rospendowski; W E Smith; J McKnight; A J Thomson
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

3.  A thermodynamic model of regulation: modulation of redox equilibria in camphor monoxygenase.

Authors:  S G Sligar; I C Gunsalus
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

4.  Structural diversities of active site in clinical azole-bound forms between sterol 14alpha-demethylases (CYP51s) from human and Mycobacterium tuberculosis.

Authors:  Koji Matsuura; Shiro Yoshioka; Takehiko Tosha; Hiroshi Hori; Koichiro Ishimori; Teizo Kitagawa; Isao Morishima; Norio Kagawa; Michael R Waterman
Journal:  J Biol Chem       Date:  2004-12-20       Impact factor: 5.157

Review 5.  Screening for novel antituberculosis agents that are effective against multidrug resistant tuberculosis.

Authors:  Makoto Matsumoto; Hiroyuki Hashizume; Hidetsugu Tsubouchi; Hirofumi Sasaki; Motohiro Itotani; Hideaki Kuroda; Tatsuo Tomishige; Masanori Kawasaki; Makoto Komatsu
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

6.  Gene expression diversity among Mycobacterium tuberculosis clinical isolates.

Authors:  Qian Gao; Katharine E Kripke; Alok J Saldanha; Weihong Yan; Susan Holmes; Peter M Small
Journal:  Microbiology (Reading)       Date:  2005-01       Impact factor: 2.777

7.  Crystal structures of metyrapone- and phenylimidazole-inhibited complexes of cytochrome P-450cam.

Authors:  T L Poulos; A J Howard
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

8.  Phe393 mutants of cytochrome P450 BM3 with modified heme redox potentials have altered heme vinyl and propionate conformations.

Authors:  Zhucheng Chen; Tobias W B Ost; Johannes P M Schelvis
Journal:  Biochemistry       Date:  2004-02-24       Impact factor: 3.162

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Biophysical characterization of the sterol demethylase P450 from Mycobacterium tuberculosis, its cognate ferredoxin, and their interactions.

Authors:  Kirsty J McLean; Ashley J Warman; Harriet E Seward; Ker R Marshall; Hazel M Girvan; Myles R Cheesman; Michael R Waterman; Andrew W Munro
Journal:  Biochemistry       Date:  2006-07-11       Impact factor: 3.162

View more
  45 in total

Review 1.  Conformational plasticity and structure/function relationships in cytochromes P450.

Authors:  Thomas C Pochapsky; Sophia Kazanis; Marina Dang
Journal:  Antioxid Redox Signal       Date:  2010-10       Impact factor: 8.401

Review 2.  The Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2009-07-25       Impact factor: 4.013

3.  The Structure of Mycobacterium tuberculosis CYP125: molecular basis for cholesterol binding in a P450 needed for host infection.

Authors:  Kirsty J McLean; Pierre Lafite; Colin Levy; Myles R Cheesman; Natalia Mast; Irina A Pikuleva; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

Review 4.  Oxidative Cyclization in Natural Product Biosynthesis.

Authors:  Man-Cheng Tang; Yi Zou; Kenji Watanabe; Christopher T Walsh; Yi Tang
Journal:  Chem Rev       Date:  2016-12-12       Impact factor: 60.622

5.  Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from Mycobacterium tuberculosis proceeds through a catalytic shunt pathway.

Authors:  Kednerlin Dornevil; Ian Davis; Andrew J Fielding; James R Terrell; Li Ma; Aimin Liu
Journal:  J Biol Chem       Date:  2017-06-30       Impact factor: 5.157

Review 6.  Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Trends Microbiol       Date:  2011-09-15       Impact factor: 17.079

7.  Biosynthesis of Strained Piperazine Alkaloids: Uncovering the Concise Pathway of Herquline A.

Authors:  Xia Yu; Fang Liu; Yi Zou; Man-Cheng Tang; Leibniz Hang; K N Houk; Yi Tang
Journal:  J Am Chem Soc       Date:  2016-10-06       Impact factor: 15.419

8.  Interaction of Mycobacterium tuberculosis CYP130 with heterocyclic arylamines.

Authors:  Larissa M Podust; Hugues Ouellet; Jens P von Kries; Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

9.  Biochemical and structural characterization of CYP124: a methyl-branched lipid omega-hydroxylase from Mycobacterium tuberculosis.

Authors:  Jonathan B Johnston; Petrea M Kells; Larissa M Podust; Paul R Ortiz de Montellano
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-20       Impact factor: 11.205

10.  Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia.

Authors:  Michael Berney; Gregory M Cook
Journal:  PLoS One       Date:  2010-01-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.